Selected research
Industry Research
Spatial Transcriptomics Platform Industry Research Report 2026
Market perspective
The global Spatial Transcriptomics Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Spatial Transcriptomics Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Spatial Transcriptomics Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Spatial Transcriptomics Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Spatial Transcriptomics Platform include STOmics, Curio Bioscience, Resolve Biosciences, Bio-Techne, Miltenyi Biotec, SeekGene, BMKMANU, CapitalBio Technology and Dynamic Biosystems, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Spatial Transcriptomics Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Spatial Transcriptomics Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Spatial Transcriptomics Platform Market by Company
STOmics
Curio Bioscience
Resolve Biosciences
Bio-Techne
Miltenyi Biotec
SeekGene
BMKMANU
CapitalBio Technology
Dynamic Biosystems
M20 Genomics
Singleron Biotechnologies
AtlasXomics
10x Genomics
Bruker
Vizgen
Spatial Transcriptomics Platform Segment by Type
Sequencing-Based Spatial Barcoding Platforms
Imaging-Based in Situ Hybridization Platforms
In Situ Sequencing Platforms
Region-of-Interest Digital Profiling Platforms
Spatial Single-Nucleus Sequencing Platforms
Other or Hybrid Platforms
Spatial Transcriptomics Platform Segment by Application
Oncology Research
Neuroscience Research
Developmental and Regenerative Biology
Immunology and Infectious Disease
Organ Physiology and Metabolic Disease
Other Life Science Research
Spatial Transcriptomics Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spatial Transcriptomics Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spatial Transcriptomics Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spatial Transcriptomics Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Spatial Transcriptomics Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sequencing-Based Spatial Barcoding Platforms
- Imaging-Based in Situ Hybridization Platforms
- In Situ Sequencing Platforms
- Region-of-Interest Digital Profiling Platforms
- Spatial Single-Nucleus Sequencing Platforms
- Other or Hybrid Platforms
Applications
- Oncology Research
- Neuroscience Research
- Developmental and Regenerative Biology
- Immunology and Infectious Disease
- Organ Physiology and Metabolic Disease
- Other Life Science Research
Companies covered
- STOmics
- Curio Bioscience
- Resolve Biosciences
- Bio-Techne
- Miltenyi Biotec
- SeekGene
- BMKMANU
- CapitalBio Technology
- Dynamic Biosystems
- M20 Genomics
- Singleron Biotechnologies
- AtlasXomics
- 10x Genomics
- Bruker
- Vizgen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Spatial Transcriptomics Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Sequencing-Based Spatial Barcoding Platforms
- 2.2.3 Imaging-Based in Situ Hybridization Platforms
- 2.2.4 In Situ Sequencing Platforms
- 2.2.5 Region-of-Interest Digital Profiling Platforms
- 2.2.6 Spatial Single-Nucleus Sequencing Platforms
- 2.2.7 Other or Hybrid Platforms
- 2.3 Spatial Transcriptomics Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Oncology Research
- 2.3.3 Neuroscience Research
- 2.3.4 Developmental and Regenerative Biology
- 2.3.5 Immunology and Infectious Disease
- 2.3.6 Organ Physiology and Metabolic Disease
- 2.3.7 Other Life Science Research
- 2.4 Assumptions and Limitations
3 Spatial Transcriptomics Platform Breakdown Data by Type
- 3.1 Global Spatial Transcriptomics Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Spatial Transcriptomics Platform Forecasted Market Size by Type (2027-2032)
4 Spatial Transcriptomics Platform Breakdown Data by Application
- 4.1 Global Spatial Transcriptomics Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Spatial Transcriptomics Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Spatial Transcriptomics Platform Market Perspective (2021-2032)
- 5.2 Global Spatial Transcriptomics Platform Growth Trends by Region
- 5.2.1 Global Spatial Transcriptomics Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Spatial Transcriptomics Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Spatial Transcriptomics Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Spatial Transcriptomics Platform Market Dynamics
- 5.3.1 Spatial Transcriptomics Platform Industry Trends
- 5.3.2 Spatial Transcriptomics Platform Market Drivers
- 5.3.3 Spatial Transcriptomics Platform Market Challenges
- 5.3.4 Spatial Transcriptomics Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Spatial Transcriptomics Platform Players by Revenue
- 6.1.1 Global Top Spatial Transcriptomics Platform Players by Revenue (2021-2026)
- 6.1.2 Global Spatial Transcriptomics Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Spatial Transcriptomics Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Spatial Transcriptomics Platform Head Office and Area Served
- 6.4 Global Spatial Transcriptomics Platform Players, Product Type & Application
- 6.5 Global Spatial Transcriptomics Platform Manufacturers Established Date
- 6.6 Global Spatial Transcriptomics Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Spatial Transcriptomics Platform Market Size (2021-2032)
- 7.2 North America Spatial Transcriptomics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Spatial Transcriptomics Platform Market Size by Country (2021-2026)
- 7.4 North America Spatial Transcriptomics Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Spatial Transcriptomics Platform Market Size (2021-2032)
- 8.2 Europe Spatial Transcriptomics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Spatial Transcriptomics Platform Market Size by Country (2021-2026)
- 8.4 Europe Spatial Transcriptomics Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Spatial Transcriptomics Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Spatial Transcriptomics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Spatial Transcriptomics Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Spatial Transcriptomics Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Spatial Transcriptomics Platform Market Size (2021-2032)
- 10.2 South America Spatial Transcriptomics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Spatial Transcriptomics Platform Market Size by Country (2021-2026)
- 10.4 South America Spatial Transcriptomics Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Spatial Transcriptomics Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Spatial Transcriptomics Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Spatial Transcriptomics Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Spatial Transcriptomics Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 STOmics
- 12.1.1 STOmics Company Information
- 12.1.2 STOmics Business Overview
- 12.1.3 STOmics Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.1.4 STOmics Spatial Transcriptomics Platform Product Portfolio
- 12.1.5 STOmics Recent Developments
- 12.2 Curio Bioscience
- 12.2.1 Curio Bioscience Company Information
- 12.2.2 Curio Bioscience Business Overview
- 12.2.3 Curio Bioscience Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.2.4 Curio Bioscience Spatial Transcriptomics Platform Product Portfolio
- 12.2.5 Curio Bioscience Recent Developments
- 12.3 Resolve Biosciences
- 12.3.1 Resolve Biosciences Company Information
- 12.3.2 Resolve Biosciences Business Overview
- 12.3.3 Resolve Biosciences Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.3.4 Resolve Biosciences Spatial Transcriptomics Platform Product Portfolio
- 12.3.5 Resolve Biosciences Recent Developments
- 12.4 Bio-Techne
- 12.4.1 Bio-Techne Company Information
- 12.4.2 Bio-Techne Business Overview
- 12.4.3 Bio-Techne Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.4.4 Bio-Techne Spatial Transcriptomics Platform Product Portfolio
- 12.4.5 Bio-Techne Recent Developments
- 12.5 Miltenyi Biotec
- 12.5.1 Miltenyi Biotec Company Information
- 12.5.2 Miltenyi Biotec Business Overview
- 12.5.3 Miltenyi Biotec Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.5.4 Miltenyi Biotec Spatial Transcriptomics Platform Product Portfolio
- 12.5.5 Miltenyi Biotec Recent Developments
- 12.6 SeekGene
- 12.6.1 SeekGene Company Information
- 12.6.2 SeekGene Business Overview
- 12.6.3 SeekGene Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.6.4 SeekGene Spatial Transcriptomics Platform Product Portfolio
- 12.6.5 SeekGene Recent Developments
- 12.7 BMKMANU
- 12.7.1 BMKMANU Company Information
- 12.7.2 BMKMANU Business Overview
- 12.7.3 BMKMANU Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.7.4 BMKMANU Spatial Transcriptomics Platform Product Portfolio
- 12.7.5 BMKMANU Recent Developments
- 12.8 CapitalBio Technology
- 12.8.1 CapitalBio Technology Company Information
- 12.8.2 CapitalBio Technology Business Overview
- 12.8.3 CapitalBio Technology Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.8.4 CapitalBio Technology Spatial Transcriptomics Platform Product Portfolio
- 12.8.5 CapitalBio Technology Recent Developments
- 12.9 Dynamic Biosystems
- 12.9.1 Dynamic Biosystems Company Information
- 12.9.2 Dynamic Biosystems Business Overview
- 12.9.3 Dynamic Biosystems Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.9.4 Dynamic Biosystems Spatial Transcriptomics Platform Product Portfolio
- 12.9.5 Dynamic Biosystems Recent Developments
- 12.10 M20 Genomics
- 12.10.1 M20 Genomics Company Information
- 12.10.2 M20 Genomics Business Overview
- 12.10.3 M20 Genomics Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.10.4 M20 Genomics Spatial Transcriptomics Platform Product Portfolio
- 12.10.5 M20 Genomics Recent Developments
- 12.11 Singleron Biotechnologies
- 12.11.1 Singleron Biotechnologies Company Information
- 12.11.2 Singleron Biotechnologies Business Overview
- 12.11.3 Singleron Biotechnologies Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.11.4 Singleron Biotechnologies Spatial Transcriptomics Platform Product Portfolio
- 12.11.5 Singleron Biotechnologies Recent Developments
- 12.12 AtlasXomics
- 12.12.1 AtlasXomics Company Information
- 12.12.2 AtlasXomics Business Overview
- 12.12.3 AtlasXomics Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.12.4 AtlasXomics Spatial Transcriptomics Platform Product Portfolio
- 12.12.5 AtlasXomics Recent Developments
- 12.13 10x Genomics
- 12.13.1 10x Genomics Company Information
- 12.13.2 10x Genomics Business Overview
- 12.13.3 10x Genomics Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.13.4 10x Genomics Spatial Transcriptomics Platform Product Portfolio
- 12.13.5 10x Genomics Recent Developments
- 12.14 Bruker
- 12.14.1 Bruker Company Information
- 12.14.2 Bruker Business Overview
- 12.14.3 Bruker Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.14.4 Bruker Spatial Transcriptomics Platform Product Portfolio
- 12.14.5 Bruker Recent Developments
- 12.15 Vizgen
- 12.15.1 Vizgen Company Information
- 12.15.2 Vizgen Business Overview
- 12.15.3 Vizgen Revenue in Spatial Transcriptomics Platform Business (2021-2026)
- 12.15.4 Vizgen Spatial Transcriptomics Platform Product Portfolio
- 12.15.5 Vizgen Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst